Halma (LON:HLMA – Get Free Report)‘s stock had its “buy” rating reaffirmed by Peel Hunt in a research report issued on Thursday, MarketBeat Ratings reports. They currently have a GBX 3,750 price objective on the stock. Peel Hunt’s price target suggests a potential upside of 5.93% from the stock’s previous close.
Several other analysts have also issued reports on the company. The Goldman Sachs Group assumed coverage on Halma in a report on Thursday, August 7th. They set a “buy” rating and a GBX 3,740 target price on the stock. Berenberg Bank raised their target price on shares of Halma from GBX 3,250 to GBX 3,750 and gave the company a “buy” rating in a research note on Wednesday, September 10th. Shore Capital restated a “hold” rating on shares of Halma in a report on Friday, September 26th. Finally, Deutsche Bank Aktiengesellschaft upped their price target on shares of Halma from GBX 3,290 to GBX 3,690 and gave the stock a “hold” rating in a research report on Friday, October 3rd. Three analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of GBX 3,455.
View Our Latest Analysis on Halma
Halma Trading Down 2.2%
Insider Activity at Halma
In other news, insider Jennifer Ward sold 15,000 shares of the stock in a transaction that occurred on Thursday, September 25th. The stock was sold at an average price of GBX 3,381, for a total transaction of £507,150. Insiders own 0.81% of the company’s stock.
Halma Company Profile
Halma is a global group of life-saving technology companies, focused on growing a safer, cleaner, healthier future for everyone, every day. Its purpose defines the three broad markets it operates in:
– Safety – Protecting people’s safety and the environment as populations grow, and enhancing worker safety.
– Environment – Addressing the impacts of climate change, pollution and waste, protecting life-critical resources and supporting scientific research.
– Health – Meeting the increasing demand for better healthcare as chronic illness rises, driven by growing and ageing populations and lifestyle changes.
Halma employs over 9,000 people in more than 20 countries, with major operations in the UK, Mainland Europe, the USA and Asia Pacific.
Featured Stories
- Five stocks we like better than Halma
- What is a Microcap Stock? Everything You Need to Know
- MarketBeat Week in Review – 11/17 – 11/21
- 3 Small Caps With Big Return Potential
- A Magnificent AI Bet? Stanley Druckenmiller’s Latest Tech Moves
- What Investors Need to Know to Beat the Market
- 12 Analysts Just Raised CrowdStrike Targets—Here’s What They See Coming
Receive News & Ratings for Halma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Halma and related companies with MarketBeat.com's FREE daily email newsletter.
